ストックスクリーナーアプリを入手
46.95
3.05%
1.39
プレマーケット:
47.27
0.32
+0.68%
前日終値:
$45.56
開ける：
$45.73
24時間の取引高:
1.19M
Relative Volume:
0.83
時価総額：
$5.63B
収益：
$47.30M
当期純損益:
$-377.94M
株価収益率:
-13.71
EPS:
-3.4256
ネットキャッシュフロー:
$-300.64M
1週間 パフォーマンス:
+6.49%
1か月 パフォーマンス:
-4.86%
6か月 パフォーマンス:
+6.68%
1年 パフォーマンス:
+50.72%
1日の値動き範囲:
$45.57
$48.25
1週間の範囲:
$43.23
$48.25
52週間の値動き範囲:
$27.07
$52.19
Scholar Rock Holding Corp Stock (SRRK) Company Profile
名前
Scholar Rock Holding Corp
セクター
電話
857-259-3860
住所
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
46.95 | 5.50B | 47.30M | -377.94M | -300.64M | -3.4256 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-21 | 開始されました | Canaccord Genuity | Buy |
| 2026-01-09 | 開始されました | Citigroup | Buy |
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-10-09 | 開始されました | BofA Securities | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-15 | 開始されました | Leerink Partners | Outperform |
| 2025-08-21 | 再開されました | Jefferies | Buy |
| 2025-07-30 | 再開されました | Raymond James | Strong Buy |
| 2025-07-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-11-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-10-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-03-28 | 開始されました | Raymond James | Strong Buy |
| 2023-10-25 | アップグレード | Jefferies | Hold → Buy |
| 2023-04-03 | 再開されました | Piper Sandler | Overweight |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-07-12 | 開始されました | Truist | Buy |
| 2022-03-23 | 開始されました | H.C. Wainwright | Buy |
| 2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | Credit Suisse | Outperform |
| 2021-01-06 | 開始されました | JP Morgan | Overweight |
| 2020-03-12 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Scholar Rock Holding Corp (SRRK) 最新ニュース
Why Scholar Rock’s Workforce Expansion Is Drawing Attention Across Biotechnology - Kalkine Media
Why Scholar Rock Stock Is Sliding Again Today - TipRanks
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Scholar Rock Holding Corporation $SRRK Shares Sold by Clearbridge Investments LLC - MarketBeat
Transcript : Scholar Rock Holding Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10 - marketscreener.com
Scholar Rock Holding Corp (SRRK) Stock Price & 30 Year Financial Data - GuruFocus
Scholar Rock Holding Corp at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Scholar Rock Holding Corporation $SRRK Stake Lessened by TD Asset Management Inc - MarketBeat
Weight-loss drug developers line up to tap lucrative market as competition heats up - Reuters
Scholar Rock (SRRK) director awarded RSUs and 4,310 stock options - Stock Titan
Scholar Rock (SRRK) director Joshua Reed receives RSU and option grants - Stock Titan
Scholar Rock (SRRK) director receives RSU and stock option grants - Stock Titan
Scholar Rock (NASDAQ: SRRK) director receives new RSU and stock option grants - Stock Titan
Scholar Rock (SRRK) director Michael Gilman awarded RSUs and stock options - Stock Titan
Scholar Rock (SRRK) director Katie Peng granted RSUs and stock options - Stock Titan
Scholar Rock (NASDAQ: SRRK) director gets RSUs and 4,310 stock options - Stock Titan
The 25 highest-paid CEOs in biopharma for 2025 with $25M+ paydays - Endpoints News
Geode Capital Management LLC Has $89.62 Million Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Norges Bank Takes Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
BNP Paribas Financial Markets Has $24.43 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Scholar Rock faces earnings test as apitegromab approval looms By Investing.com - Investing.com Nigeria
Evercore ISI initiates Scholar Rock stock coverage with outperform rating - Investing.com
Scholar Rock Holding Corporation Files Form 8-K with SEC on June 4, 2026 – Corporate Information and Shareholder Actions - Minichart
Scholar Rock faces earnings test as apitegromab approval looms - Investing.com
Scholar Rock (SRRK) holders approve directors, auditor and executive pay - Stock Titan
Scholar Rock Holding Corp Annual Shareholders Meeting Transcript - GuruFocus
Scholar Rock (SRRK) Holds Near Resistance as Biotech Momentum WaversFundamentals - newsline.com
Scholar Rock Holding Corp stock hits 52-week high at 51.65 USD - Investing.com Nigeria
Scholar Rock (NASDAQ:SRRK) Sets New 1-Year HighHere's Why - MarketBeat
Scholar Rock Holding Corp stock hits 52-week high at 51.65 USD By Investing.com - Investing.com South Africa
Scholar Rock (SRRK) Surges Over 6% – Key Levels to Watch After the JumpCall Flow Alert - The Legal Advocate
Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - marketscreener.com
Scholar Rock Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineShort-Term Outlook - The Legal Advocate
SRRK Stock Price, Quote & Chart | SCHOLAR ROCK HOLDING CORP (NASDAQ:SRRK) - ChartMill
103,191 Shares in Scholar Rock Holding Corporation $SRRK Bought by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Biotech Scholar Rock to webcast Jefferies healthcare talk June 3 - Stock Titan
Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference - Business Wire
Three Biotechs That Are Top Takeover Targets - Yahoo Finance
iA Global Asset Management Inc. Makes New $5.43 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Charles Schwab Investment Management Inc. Acquires 25,060 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Redmile Group owns 7.6% of Scholar Rock (SRRK) via funds and affiliates - Stock Titan
T. Rowe Price holds 5.4% of Scholar Rock (NASDAQ: SRRK) - Stock Titan
Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises - Investing.com Nigeria
Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises By Investing.com - Investing.com South Africa
Transcript : Scholar Rock Holding Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08 - marketscreener.com
HC Wainwright Has Positive View of Scholar Rock Q2 Earnings - MarketBeat
A Look At Scholar Rock (SRRK) Valuation After FDA Acceptance Of Apitegromab BLA - Sahm
State of New Jersey Common Pension Fund D Buys New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Scholar Rock Holding Corp (SRRK) 財務データ
収益
当期純利益
現金流量
EPS
Scholar Rock Holding Corp (SRRK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Woods Keith | Chief Operating Officer |
Apr 16 '26 |
Sale |
49.57 |
10,220 |
506,651 |
620,055 |
| Vaishnaw Akshay | President of R&D |
Apr 16 '26 |
Sale |
49.57 |
12,246 |
607,089 |
630,542 |
| Sinha Vikas | Chief Financial Officer |
Apr 16 '26 |
Sale |
49.57 |
10,410 |
516,071 |
619,856 |
| Hallal David | Chief Executive Officer |
Apr 16 '26 |
Sale |
49.57 |
30,615 |
1,517,723 |
1,639,034 |
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):